Home > Aegerion Pharmaceuticals Salary

Aegerion Pharmaceuticals Salary

  • 26
  • 76
  • 58
Aegerion Pharmaceuticals average salary is $66,558, median salary is $75,000 with a salary range from $43,264 to $75,000.
Aegerion Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Aegerion Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 4 Aegerion Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Law Clerk 43,264-43,264 Salt Lake City, UT, 84101 2018 Aegerion Pharmaceuticals Law Clerk Salaries (1)
Aegerion Pharmaceuticals Salt Lake City, UT Salaries
Attorney 64,522-64,522 Salt Lake City, UT, 84101 2015 Aegerion Pharmaceuticals Attorney Salaries (2)
Aegerion Pharmaceuticals Salt Lake City, UT Salaries
Attorney 75,000-75,000 Salt Lake City, UT, 84101 2013 Aegerion Pharmaceuticals Attorney Salaries (2)
Aegerion Pharmaceuticals Salt Lake City, UT Salaries
Staff Attorney 75,000-75,000 Salt Lake City, UT, 84101 2013 Aegerion Pharmaceuticals Staff Attorney Salaries (2)
Aegerion Pharmaceuticals Salt Lake City, UT Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Aegerion Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Aegerion Pharmaceuticals Jobs
See more Aegerion Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Aegerion Pharmaceutica... Information
  • Aegerion Pharmaceuticals, Inc
  • Industry: BioTech/Drugs
  • City: Cambridge, MA
  • Aegerion Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company focused on the development and commercialization of promising pharmaceuticals to treat cardiovascular and metabolic disease. The Company's initial focus will be on hyperlipidemia. Its most advanced products have demonstrated significant LDL lowering activity in human trials and are currently in Phase II testing. Aegerion is also in active discussions regarding in-licensing opportunities in the cardiovascular or metabolic therapeutic areas. Incorporated in February 2005 and headquartered in Bridgewater, New Jersey, Aegerion Pharmaceuticals is a specialty pharmaceutical company focusing on the development and commercialization of promising therapeutics to treat cardiovascular / metabolic